• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of nuclear receptor coactivator PDIP1 in non-alcholic steatohepatitis

Research Project

Project/Area Number 23590959
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Gastroenterology
Research InstitutionGunma University

Principal Investigator

Sato Ken  群馬大学, 医学部附属病院, 助教 (40396619)

Co-Investigator(Kenkyū-buntansha) 山崎 勇一  群馬大学, 医学(系)研究科(研究院), 助教 (00582404)
堀口 昇男  群馬大学, 医学部附属病院, 助教 (10550022)
Co-Investigator(Renkei-kenkyūsha) SATOH tetsurou  群馬大学, 医学部附属病院, 講師 (40302484)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords脂質 / 病理学 / 発現制御 / 遺伝子 / 動物
Outline of Final Research Achievements

Methionine-choline-deficient diet (MCD diet) has been established to use to make an animal model of non-alchoholic steatohepatitis. In PPAR gamma DNA-binding domain-interacting protein1 (PDIP1) knockout mice, serum ALT and TG, and hepatic fatty deposition, inflammation, and fibrosis were significantly reduced compared to wild type mice. Besides, the expressions of hepatic lipid-related genes have changed and hepatic inflammatory cytokines and fibrogenic genes were significantly reduced compared to wild type mice. Thus, we showed that non-alchoholic steatohepatitis was ameliorated in PDIP1 knockout mice.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (15 results)

All 2014 2013 2012 2011 2010 Other

All Journal Article (5 results) Presentation (10 results)

  • [Journal Article] Transforming growth factor-αactivates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation2013

    • Author(s)
      Tahara H, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Hashizume H, Kakizaki S, Takagi H, Ozaki I, Arai H, Hirato J, Jesenofsky R, Masamune A, Mori M
    • Journal Title

      Lab Invest

      Volume: 93(6) Pages: 720-32

    • Related Report
      2013 Final Research Report
  • [Journal Article] Hashizume H, Sato K, Yamazaki Y, Horiguchi N, Kakizaki S, Mori M2013

    • Author(s)
      A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts
    • Journal Title

      Acta Med Okayama

      Volume: 67(1) Pages: 45-53

    • Related Report
      2013 Final Research Report
  • [Journal Article] Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, Ichikawa T, Kakizaki S, Takagi H, Izumi T, Mori M2012

    • Author(s)
      Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence
    • Journal Title

      Br J Pharmacol

      Volume: 165(4b) Pages: 1173-87

    • Related Report
      2013 Final Research Report
  • [Journal Article] Transforming growth factor-αattenuates hepatic fibrosis : possible involvement of matrix metalloproteinase-12011

    • Author(s)
      Ohyama T, Yamazaki Y, Sato K, Horiguchi N, Ichikawa T, Kakizaki S, Takagi H, Mori M
    • Journal Title

      Liver Int

      Volume: 31(4) Pages: 572-84

    • Related Report
      2013 Final Research Report
  • [Journal Article] Tojima H, Kakizaki S, Kosone T, Horiguchi N, Yamazaki Y, Sato K, Takagi H, Mori M2011

    • Author(s)
      Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis
    • Journal Title

      Hepatol Int

      Volume: 5

    • Related Report
      2013 Final Research Report
  • [Presentation] Comparison of Clinical Characteristics and Survival between Patients with HCC from NASH and Those from Non-B, Non-C and Non-NASH after Curative Resection for HCC2014

    • Author(s)
      Hashizume H, Sato K, et al
    • Organizer
      APASL2013
    • Place of Presentation
      ブリスベン
    • Related Report
      2013 Final Research Report
  • [Presentation] Werner syndrome and NASH2013

    • Author(s)
      Hashizume H, Sato K, et al
    • Organizer
      APASL2013
    • Place of Presentation
      シンガポール
    • Related Report
      2013 Final Research Report
  • [Presentation] Amelioration of hepatic steatosis in obese mice by MK-0626, a selectiveα-amino amide dipeptidyl peptidase-4 inhibitor2013

    • Author(s)
      Ohyama T, Sato K, et al
    • Organizer
      DDW2013
    • Place of Presentation
      オーランド
    • Related Report
      2013 Final Research Report
  • [Presentation] マウスアルコール脂肪肝炎モデルにおける細胞特異的なSTAT3の役割2013

    • Author(s)
      堀口昇男, 佐藤賢, 山崎勇一, ら
    • Organizer
      アルコール医学生物学研究会学術集会
    • Related Report
      2013 Final Research Report
  • [Presentation] Pancreatic stellate cell activation by transforming growth factor-α: possible involvement of matrix metalloproteinase-1 upregulation2012

    • Author(s)
      Tahara H, Sato K, et al
    • Organizer
      EASL
    • Place of Presentation
      アムステルダム
    • Related Report
      2013 Final Research Report
  • [Presentation] 臓器線維化(肝・膵を中心)研究・診療の最前線抗酸化作用を有するCa拮抗薬アゼルニジピンの肝線維化抑制効果とそのメカニズム臨床応用の可能性2012

    • Author(s)
      大山達也, 佐藤賢, 山崎勇一, 堀口昇男, ら
    • Organizer
      日本消化器病学会
    • Related Report
      2013 Final Research Report
  • [Presentation] 肝線維化の病態解明と治療への展開カルシウム拮抗薬アゼルニジピンによる肝線維化抑制臨床応用への展望2012

    • Author(s)
      大山達也, 佐藤賢, 山崎勇一, 堀口昇男, ら
    • Organizer
      日本肝臓学会
    • Place of Presentation
      (共同演者)
    • Related Report
      2013 Final Research Report
  • [Presentation] MIF (マクロファージ遊走阻止因子)は高脂肪食による肝障害、脂質沈着(Steatosis)、および肝線維化を抑制する2012

    • Author(s)
      堀口昇男, 佐藤賢, 山崎勇一, ら
    • Organizer
      日本肝臓学会
    • Related Report
      2013 Final Research Report
  • [Presentation] NASH/NAFLDの病因・病態と予後NASHの肝線維化進行度別予後とNASH-HCC症例の予後2010

    • Author(s)
      橋爪洋明, 佐藤賢, 山崎勇一, 堀口昇男, ら
    • Organizer
      日本肝臓学会
    • Place of Presentation
      (共同演者)
    • Related Report
      2013 Final Research Report
  • [Presentation] TGF-alpha Attenuates Hepatic Fibrosis : Possible Involvement of Matrix Metalloproteinase-1

    • Author(s)
      Ohyama T; Sato K, et al
    • Organizer
      DDW2011
    • Place of Presentation
      シカゴ
    • Related Report
      2013 Final Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi